Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreaticoduodenectomy | 5 | 2020 | 509 | 2.460 |
Why?
|
Pancreatectomy | 7 | 2021 | 811 | 1.860 |
Why?
|
Pancreatic Fistula | 3 | 2020 | 148 | 1.820 |
Why?
|
Hepatectomy | 4 | 2019 | 557 | 1.230 |
Why?
|
Pancreatic Neoplasms | 9 | 2021 | 5367 | 1.140 |
Why?
|
Laparoscopy | 6 | 2018 | 2030 | 0.920 |
Why?
|
Drainage | 2 | 2019 | 1156 | 0.850 |
Why?
|
Liver Neoplasms | 5 | 2019 | 4308 | 0.740 |
Why?
|
Postoperative Complications | 9 | 2020 | 15612 | 0.670 |
Why?
|
Smad4 Protein | 1 | 2019 | 191 | 0.610 |
Why?
|
Diagnosis-Related Groups | 1 | 2018 | 448 | 0.550 |
Why?
|
Failure to Thrive | 1 | 2016 | 140 | 0.490 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 2015 | 50 | 0.480 |
Why?
|
Length of Stay | 5 | 2020 | 6418 | 0.470 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2021 | 1727 | 0.470 |
Why?
|
Dehydration | 1 | 2016 | 216 | 0.470 |
Why?
|
Device Removal | 1 | 2019 | 629 | 0.450 |
Why?
|
Patient Readmission | 2 | 2018 | 3269 | 0.420 |
Why?
|
Laparotomy | 1 | 2015 | 456 | 0.410 |
Why?
|
Hospital Costs | 1 | 2018 | 947 | 0.410 |
Why?
|
Population Surveillance | 2 | 2019 | 2595 | 0.390 |
Why?
|
Colorectal Neoplasms | 3 | 2019 | 6925 | 0.370 |
Why?
|
Perioperative Care | 1 | 2018 | 1037 | 0.370 |
Why?
|
Gastroplasty | 1 | 2012 | 157 | 0.360 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2015 | 517 | 0.360 |
Why?
|
Alanine Transaminase | 1 | 2012 | 601 | 0.340 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.330 |
Why?
|
Postoperative Care | 1 | 2016 | 1467 | 0.330 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2291 | 0.330 |
Why?
|
Neuroendocrine Tumors | 1 | 2015 | 641 | 0.310 |
Why?
|
Cause of Death | 1 | 2019 | 3683 | 0.300 |
Why?
|
Surgical Mesh | 1 | 2010 | 311 | 0.290 |
Why?
|
Propensity Score | 3 | 2019 | 1911 | 0.280 |
Why?
|
Neoadjuvant Therapy | 6 | 2021 | 2827 | 0.280 |
Why?
|
Hernia, Ventral | 1 | 2010 | 218 | 0.270 |
Why?
|
Neoplasm Staging | 5 | 2019 | 11116 | 0.270 |
Why?
|
Catheter Ablation | 1 | 2019 | 2634 | 0.260 |
Why?
|
Intestinal Diseases | 1 | 2010 | 503 | 0.260 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1489 | 0.240 |
Why?
|
Gastric Bypass | 1 | 2012 | 818 | 0.230 |
Why?
|
Risk Assessment | 3 | 2019 | 23972 | 0.210 |
Why?
|
Databases, Factual | 4 | 2019 | 7960 | 0.210 |
Why?
|
Aged | 15 | 2020 | 169042 | 0.200 |
Why?
|
Obesity, Morbid | 1 | 2012 | 1276 | 0.190 |
Why?
|
Middle Aged | 16 | 2020 | 220584 | 0.180 |
Why?
|
Postoperative Period | 2 | 2015 | 1813 | 0.160 |
Why?
|
Suction | 1 | 2020 | 266 | 0.160 |
Why?
|
Jaundice, Obstructive | 1 | 2018 | 20 | 0.160 |
Why?
|
Retrospective Studies | 12 | 2021 | 80566 | 0.150 |
Why?
|
Male | 17 | 2020 | 360358 | 0.150 |
Why?
|
Female | 18 | 2021 | 392148 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9277 | 0.130 |
Why?
|
Pancreatic Ducts | 1 | 2018 | 329 | 0.130 |
Why?
|
Treatment Outcome | 7 | 2018 | 64568 | 0.130 |
Why?
|
Perioperative Period | 1 | 2017 | 250 | 0.130 |
Why?
|
Intraoperative Care | 1 | 2019 | 767 | 0.120 |
Why?
|
Aged, 80 and over | 5 | 2018 | 58894 | 0.120 |
Why?
|
Humans | 20 | 2021 | 760617 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2021 | 1051 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1663 | 0.100 |
Why?
|
Logistic Models | 2 | 2018 | 13245 | 0.100 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39063 | 0.100 |
Why?
|
Adult | 8 | 2019 | 220969 | 0.100 |
Why?
|
Reoperation | 2 | 2019 | 4300 | 0.100 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6807 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2018 | 1299 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3593 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2913 | 0.090 |
Why?
|
Case-Control Studies | 2 | 2019 | 22148 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12142 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2018 | 1926 | 0.070 |
Why?
|
Intestinal Neoplasms | 1 | 2010 | 314 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2018 | 2329 | 0.070 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 432 | 0.070 |
Why?
|
Risk Factors | 3 | 2018 | 74115 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10073 | 0.070 |
Why?
|
Young Adult | 3 | 2018 | 59179 | 0.070 |
Why?
|
Health Status | 1 | 2018 | 4075 | 0.060 |
Why?
|
Prognosis | 3 | 2021 | 29600 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6224 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10505 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6340 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13495 | 0.050 |
Why?
|
United States | 3 | 2019 | 72272 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18381 | 0.050 |
Why?
|
Weight Loss | 1 | 2012 | 2682 | 0.050 |
Why?
|
Medicare | 1 | 2018 | 6765 | 0.040 |
Why?
|
Insulin | 1 | 2012 | 6593 | 0.040 |
Why?
|
Recurrence | 1 | 2010 | 8426 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 39913 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13635 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30016 | 0.030 |
Why?
|
Body Mass Index | 1 | 2012 | 12943 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 54360 | 0.030 |
Why?
|
Pancreas | 1 | 2020 | 1690 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20556 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11736 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 88234 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Animals | 1 | 2019 | 168201 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36402 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12447 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12719 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21337 | 0.010 |
Why?
|
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_